Analysts’ expectations for Revolution Medicines Inc (RVMD) stock: $81.17 price target in 12 months

Ulysses Smith

At the time of writing, Revolution Medicines Inc [RVMD] stock is trading at $57.99, up 6.44%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RVMD shares have gain 7.37% over the last week, with a monthly amount glided 32.04%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on October 21, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $90. Truist started tracking the stock assigning a Buy rating and suggested a price target of $99 on September 05, 2025. Piper Sandler initiated its recommendation with a Overweight and recommended $75 as its price target on August 19, 2025. Wells Fargo started tracking with a Overweight rating for this stock on August 15, 2025, and assigned it a price target of $67. In a note dated July 15, 2025, Goldman initiated an Buy rating and provided a target price of $65 on this stock.

For the past year, the stock price of Revolution Medicines Inc fluctuated between $29.17 and $62.40. Currently, Wall Street analysts expect the stock to reach $81.17 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $57.99 at the most recent close of the market. An investor can expect a potential return of 39.97% based on the average RVMD price forecast.

Analyzing the RVMD fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.42 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 56.05 points at the first support level, and at 54.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 59.27, and for the 2nd resistance point, it is at 60.56.

Ratios To Look Out For

It is important to note that Revolution Medicines Inc [NASDAQ:RVMD] has a current ratio of 11.79. In addition, the Quick Ratio stands at 11.79 and the Cash Ratio stands at 2.18.

Transactions by insiders

Recent insider trading involved MARK A GOLDSMITH, Director, that happened on Oct 17 ’25 when 10000.0 shares were purchased. Officer, JEFFREY TODD CISLINI completed a deal on Oct 17 ’25 to buy 12000.0 shares. Meanwhile, Director MARK A GOLDSMITH bought 10000.0 shares on Oct 16 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.